Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma

3 Sept 2018

Abstract excerpt

Breast cancer is a very heterogeneous disease. The intrinsic molecular subtypes can explain the intertumoral heterogeneity and the cancer stem cell (CSC) hypothesis can explain the intratumoral heterogeneity of this kind of tumor. CD44+/CD24- phenotype and ALDH1 expression are the major CSC markers described in invasive breast cancer. In the present study, 144 samples of invasive breast carcinoma, no special type...

Source

Identifiers

PMID: 30362671
DOI: 10.4081/ejh.2018.2943

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinomaPMID 30362671Read ↗

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.Semantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological typesSemantic proximity Read ↗

Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.Semantic proximity Read ↗

CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancerSemantic proximity Read ↗

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic FactorsSemantic proximity Read ↗

Cancer stem cells and their implication in breast cancer.Semantic proximity Read ↗

The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.Semantic proximity Read ↗

Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.Semantic proximity Read ↗

High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.Semantic proximity Read ↗

Novel molecular regulators of breast cancer stem cell plasticity and heterogeneitySemantic proximity Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.